NBIX vs USPH · P/E 45, rev $1.77B vs P/E 34, rev $412.3M
Neurocrine Biosciences Inc (NBIX) versus US Physicalrapy Inc (USPH) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
US Physicalrapy Inc (USPH) is a medical care facilities company listed on US.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported USPH revenue for 2026-06-30 was $412.3M. Net income was $14.9M. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. USPH currently screens at market cap $1.13B and trailing P/E 34.2.
Not investment advice. Open the NBIX and USPH stock pages for the full models.
Not investment advice.